0002056818-25-000001.txt : 20250220 0002056818-25-000001.hdr.sgml : 20250220 20250220113639 ACCESSION NUMBER: 0002056818-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250220 DATE AS OF CHANGE: 20250220 EFFECTIVENESS DATE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pairidex Inc. CENTRAL INDEX KEY: 0002056818 ORGANIZATION NAME: IRS NUMBER: 991117243 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-538760 FILM NUMBER: 25643922 BUSINESS ADDRESS: STREET 1: 4340 DUNCAN AVE. STREET 2: SUITE 213 CITY: ST. LOUIS STATE: MO ZIP: 63110 BUSINESS PHONE: 301-580-8895 MAIL ADDRESS: STREET 1: 4340 DUNCAN AVE. STREET 2: SUITE 213 CITY: ST. LOUIS STATE: MO ZIP: 63110 D 1 primary_doc.xml X0708 D LIVE 0002056818 Pairidex Inc. 4340 DUNCAN AVE. SUITE 213 ST. LOUIS MO MISSOURI 63110 301-580-8895 DELAWARE None None Corporation true 2023 Andrew Young 4340 DUNCAN AVE. SUITE 213 ST. LOUIS MO MISSOURI 63110 Executive Officer Director Director; Chief Executive Officer Allyson Mayer 4340 DUNCAN AVE. SUITE 213 ST. LOUIS MO MISSOURI 63110 Executive Officer Chief Operating Officer Crystal Winkeler 4340 DUNCAN AVE. SUITE 213 ST. LOUIS MO MISSOURI 63110 Director Director Todd Druley 4340 DUNCAN AVE. SUITE 213 ST. LOUIS MO MISSOURI 63110 Director Director Biotechnology Decline to Disclose 06b false 2024-05-15 false true true true false 25000 1090000 1090000 0 false 16 0 0 0 A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and/or directors. An estimate of such amount is unknown at this time. false Pairidex Inc. Andrew Young, MD, PhD Andrew Young, MD, PhD Chief Executive Officer 2025-02-20